Drugs / SAR279356
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01389700 | Oct 2011 → Dec 2012 | — | Sanofi | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR279356 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01389700 ↗ |
| Route | Intravenous | “Route of administration: intravenous infusion” NCT01389700 ↗ |